Sabinsa Corporation was awarded the Research & Development Council of New Jersey’s 2005 Thomas Alva Edison Patent Award in the Enabling Technology /Small Company category for its U.S. Patent #6,849,645″, method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives.” The Thomas Alva Edison Patent Awards, which recognize the most revolutionary product innovations and important scientific breakthroughs originating in New Jersey, will be presented at the Council’s annual fall dinner on November 3, 2005, at the North Maple Inn, Basking Ridge, NJ. Sabinsa Corporation also received this award in 2004 for ForsLean U.S. Patent #5,804,596, “Method of preparing a forskolin composition for use in promoting lean body mass and treating mood disorders.”
“We strive to provide the most innovative, functional ingredients that are supported by extensive scientific research, and this award is a wonderful recognition of our efforts in this arena,” stated Dr. Muhammed Majeed, founder and CEO, Sabinsa Corporation.
Companies throughout New Jersey are invited to submit patents for consideration for the Thomas Alva Edison Patent Awards. Each patent is reviewed thoroughly by the Council, which is comprised of senior representatives from industry, academia and government. Winners are then selected based on the novelty of the invention and its contribution to the advance -ment of the relevant field, as well its utility and socio-economic value.
Tetrahydropiperine, the active compound in Cosmoperine®, is a derivative of piperine, an alkaloid naturally found in black pepper and long pepper. This patent encompasses the novel applications of Tetrahydropiperine in enhancing the bioavailability of nutrients, drugs and other active compounds. When products are formulated with Cosmoperine, poorly absorbed ingredients more easily permeate through the skin and gastrointestinal tract. For more information visit www.sabinsacosmetics.com.